At CHEST 2024, October 6 to 9 in Boston, you’ll have your choice of 300+ educational sessions covering every aspect of clinical chest medicine. Learn more.
Jean Elwing, MD, FCCP
Jean Elwing, MD, FCCP
During CHEST 2024, taking place October 6 to 9 in Boston, you’ll learn about diverse topics, from pulmonary hypertension in pregnancy to supporting the failing right ventricle.
The presentations and sessions on cardiovascular and pulmonary vascular medicine at CHEST 2024 are designed to “appeal to every learner,” said Jean Elwing, MD, FCCP. “We're using lecture formats, audience response systems, interactive sessions, master classes, and live learning.” The goal behind this emphasis on expert speakers, interaction, and audience involvement is to help you learn a lot—and then retain the information once you’re back home.
Take a look at some of the topics Dr. Elwing, Chair of the Cardiovascular and Pulmonary Vascular Disease Curriculum Group and the Pulmonary Vascular and Cardiovascular Network, is looking forward to at CHEST’s biggest educational event of the year.
Mock PERT interactive session
The session Dr. Elwing is perhaps most excited about is a mock pulmonary embolism response team (PERT) interactive session.
“We’ll have a radiologist, an echocardiographer, a cardiothoracic surgeon, and PERT experts to walk you through cases so you can feel what a real PERT interaction is like,” she said. Not all institutions have these expert teams in place, which activate when patients come in with a life-threatening pulmonary embolism, Dr. Elwing pointed out.
After attending this session, you may feel that such a team is needed in your institution—and experts will be on hand to help guide you through what’s needed to develop a team. Having a PERT is resource-intensive, which perhaps accounts for its scarcity outside of large medical centers. “But having this team can definitely impact outcomes for patients who are severely ill with pulmonary emboli,” said Dr. Elwing.
Key session
PE Response Team: A MOCK Discussion
New guidelines
You’ll also be able to hear about recent research into pulmonary vascular and cardiovascular disease, including the impact of metabolic status on outcomes in heart failure with preserved ejection fraction (HFpEF). There are many newly available drugs that can alter metabolic health, noted Dr. Elwing. Experts will share feedback about when it’s appropriate to use these newer therapies with patients.
There are also new guidelines around managing HFpEF that Dr. Elwing is eager to highlight. “That is an area where I think we are less aware of the new findings, and there is a great need to implement these changes,” she said. “I wanted to make sure that we review them and give the audience an opportunity to discuss with experts why following these guidelines is so important.”
Key sessions
Metabolic Health and PH: Current Understanding, Research Updates, and Future Directions
Preserved But Failing: Emerging Perspectives on Heart Failure With Preserved Ejection Fraction
At CHEST 2024, expect to have fun and make friends while building relationships and interacting with people at all levels of the profession, Dr. Elwing said. She added that CHEST is always on the lookout for people to get involved with giving presentations and developing courses. “If you find CHEST to be a good fit for your medical education home, you’ll be able to grow here with us,” she said.